Thus, the BCLIN25-miR-125b-ERBB2 axis was identified to upregulate ERBB2 expression, thereby indicating BCLIN25 as a bona fide MS-lincRNA for HER2 breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.